May 12, 2026 – In a monumental step forward for women’s health globally, Polycystic Ovary Syndrome (PCOS), a condition affecting an estimated 170 million women worldwide, has been officially rebranded as Polyendocrine Metabolic Ovarian Syndrome (PMOS). This significant nomenclature change, the culmination of a global consensus process involvi